Healthcare and Medical IoT

Abstract

Detection of analytes in the context of nano-diagnostics for preventive medicine and global public health may be within our grasp. But, it appears to be far removed from the reality of the world where 80% of the people live (non-OECD nations). The 80% of the world, however, cannot ignore other afflictions, for example, cancer, diabetes, cardiovascular malfunctions and pulmonary diseases, to name a few. Which means, in the biomedical domain, the rest of the world must find ways to use therapeutic advances, for example, human induced adult pluripotent stem cells, plant based bio-pharmaceuticals, traditional biologics (monoclonal antibody producing autologous cells), metabolomic sensor networks (in vivo wireless communication networks monitoring analytes and transmitting data from inside the body), molecular robotics (ingested micro-machines removing intestinal polyps) and nano-machines for targeted apoptosis, precision cell death and time-sensitive drug delivery.